Mirum Pharmaceuticals, Inc. (MIRM)
81.35
-1.58
(-1.91%)
USD |
NASDAQ |
Oct 05, 16:00
81.35
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals EPS Diluted (Quarterly) : -1.061 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.061 |
| March 31, 2026 | -13.43 |
| December 31, 2025 | -0.111 |
| September 30, 2025 | 0.051 |
| June 30, 2025 | -0.1179 |
| March 31, 2025 | -0.3002 |
| December 31, 2024 | -0.4947 |
| September 30, 2024 | -0.2979 |
| June 30, 2024 | -0.5216 |
| March 31, 2024 | -0.5387 |
| December 31, 2023 | -0.7095 |
| September 30, 2023 | -0.5739 |
| June 30, 2023 | -1.943 |
| March 31, 2023 | -0.7997 |
| December 31, 2022 | -0.9915 |
| Date | Value |
|---|---|
| September 30, 2022 | -1.022 |
| June 30, 2022 | -0.837 |
| March 31, 2022 | -1.170 |
| December 31, 2021 | 1.882 |
| September 30, 2021 | -1.551 |
| June 30, 2021 | -1.450 |
| March 31, 2021 | -1.678 |
| December 31, 2020 | -1.425 |
| September 30, 2020 | -0.8557 |
| June 30, 2020 | -0.928 |
| March 31, 2020 | -0.8626 |
| December 31, 2019 | -0.7809 |
| September 30, 2019 | -0.6562 |
| June 30, 2019 | -0.5897 |
| March 31, 2019 | -0.2591 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Incyte Corp. | 2.812 |
| Insmed, Inc. | -0.0609 |
| Galectin Therapeutics, Inc. | -0.1393 |
| Kodiak Sciences, Inc. | -1.048 |
| Praxis Precision Medicines, Inc. | -2.874 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.23M |
| Revenue (Quarterly) | 176.24M |
| Total Expenses (Quarterly) | 243.47M |
| Enterprise Value | 5.695B |
| Gross Profit Margin (Quarterly) | 82.65% |
| Profit Margin (Quarterly) | -38.14% |
| Earnings Yield | -17.88% |
| Normalized Earnings Yield | -6.879 |